摘要 |
An object of the present invention is to use fusion proteins of cancer-specific antigens and cytokines as a preventive or therapeutic agent for cancer. The present invention provides a pharmaceutical composition for the prevention or treatment of a cancer, comprising as active ingredients fusion proteins each comprising a cancer-specific antigen with a cytokine selected from the group consisting of human IL2 (hIL2), human IL4 (hIL4), human IL7 (hIL7), human GMCSF (hGMCSF), mouse IL4 (mIL4), and mouse GMCSF (mGMCSF). |